Kabra Drugs has informed that a meeting of the Board of Directors of the Company will be held on February 13, 2016, to approve the Unaudited financial results of the Company for the quarter ended December 31, 2015; and to delegate Board power to Stakeholders Relationship Committee to issue duplicates Share Certificates. Further, as per the Company’s Code of Conduct for Prevention of Insider Trading read with Securities Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015, the Trading window for dealing in Equity Shares of the Company shall remain closed from February 03, 2016 to February 16, 2016 for the purpose of considering the Unaudited Financial Result of the Company for the Quarter ended on December 31, 2015. Therefore, all the Designed Employees (including Directors) of the Company have been intimated not to enter into any transaction involving the securities of the Company during the aforesaid period of closure of Trading Window. The ‘Trading window’ shall reopen for dealing in securities in the Equity shares of the Company from the start of the business hours on February 17, 2016.
The above information is a part of company’s filings submitted to BSE.